Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

9
Abbott (ABT) Q2 Earnings & Revenues Top Estimates, View Up

4m zacks
Abbott Laboratories (ABT - Free Report) reported second-quarter 2018 adjusted earnings from continuing operations of 73 cents per share, beating the Zacks Consensus Estimate by a couple of cents. The bottom line also improved 17.7% year over year and exceeded the company’s guided range of 70-72 cents. Moreover, reported earnings from continuing operation in the quarter came in at 40 cents per share compared with the year-ago figure of 15 cents.
ABT ALGN ABT GHDX

7
How Big Formula influences parents from the supermarket to Trump's White House

56m abc.net.au
Infant formula is a wonder product for some working mums and those who can't or don't want to breastfeed.
ABT NYTAB ABT

7
Abbott Labs raises 2018 earnings forecast, shares hit record high - Channel NewsAsia

3h channelnewsasia
REUTERS: Abbott Laboratories raised its full-year earnings forecast and topped estimates for quarterly profit on Wednesday, powered by demand for its glucose monitoring device for diabetics and gains from its multibillion dollar acquisitions.
ABT ALR ALR.PRB ABT

7
Pay down debt or save money? How to allocate your cash

5h nzherald.co.nz
It's one of the most common questions financial advisers hear: should I prioritize paying down debt or building up savings?
ABT ABT

24
Abbott (ABT) Beats on Earnings and Revenues in Q2

6h zacks
Abbott Laboratories (ABT - Free Report) is an Illinois-based company focused on bringing a diverse line of healthcare products to the market.
ABT OCUL JAKK FTRPR ABT FTR

7
Abbott Labs tops profit estimates, raises full-year earnings forecast

6h channelnewsasia
REUTERS: Abbott Laboratories raised its full-year earnings forecast and reported a quarterly profit that beat analysts' estimates, powered by higher sales across its businesses.
ABT ABT

7
Abbott Laboratories 2018 Q2 - Results - Earnings Call Slides

6h seekingalpha
The following slide deck was published by Abbott Laboratories in conjunction with their 2018 Q2 earnings call.
ABT ABT

37
3 Big Stock Charts for Wednesday: United Technologies, Abbott Laboratories and Leggett & Platt | InvestorPlace

7h investorplace
The market didn’t start Tuesday’s action on the best foot. But, some encouraging words from Federal Reserve Chairman Jerome Powell soothed investors’ worries, pushing stocks collectively back into the black by an average of 0.4%. Overstock.com (NASDAQ:OSTK) led the way with its 10%-plus gain, though beyond, noteworthy pacesetters were few and far between.
ABT OSTK NFLX NYTAB UTX ABT LEG

25
Boston Scientific Is A Solid Buy Opportunity In 2018

2018-07-17 seekingalpha
Endoscopy, Urology, and Pelvic Health segments are proving to be major growth drivers for Boston Scientific in 2018.
ABT BSX JNJ SYK ABT EW MDT GI

12
Gentherm Appoints James Paloyan as Senior Vice President and General Manager of its Medical Business

2018-07-17 globenewswire
NORTHVILLE, Mich., July 17, 2018 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader and developer of innovative thermal management technologies, today announced that James Paloyan has joined the Company as Senior Vice President and General Manager of its medical business.
ABT CAH ABT THRM

8
Radius Health Strengthens Senior Management Team with Appointment of Chhaya Shah as Senior Vice President of Technical Operations

2018-07-16 globenewswire
WALTHAM, Mass., July 16, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq:RDUS) today announced the appointment of Chhaya Shah as Senior Vice President of Technical Operations.
ABT SGYP SGYPW RDUS ABT

97
March To Freedom Fund Mid-Year Review

2018-07-13 seekingalpha
The first half of 2018 is already over, so it is time to look back at how our portfolio performed, the purchases we made and to check our income growth.
SOJA LMT GIS XOM O.PRF TWX OPRF CVS ABT NKE HON AAPL ABBV DIS ABT VTR HON SO GILD O MA TWC RB CMI TGT V AFL PEP JNJ CVX DG MSFT SBUX ABBV QCOM

14
Can Established Pharmaceuticals Up Abbott (ABT) Q2 Earnings?

2018-07-12 zacks
Abbott Laboratories’ (ABT - Free Report) Established Pharmaceuticals Division (EPD) business has been recording operational sales growth in the last few quarters. We expect this strength to further get reflected in second-quarter 2018 results, scheduled for release on Jul 18.
ABT RMD SYK MCK RSMDF RMD ABT

56
Danger Zone: Investors Who Don't Insist On Fiduciary Duties

2018-07-10 seekingalpha
After initially invalidating the rule in March, the Fifth Circuit Court of Appeals officially issued an order vacating the rule on June 21st.
WFCNP MS.PRE WFC.PRL MS.PRF NFLX WFC.PRJ MS.PRG MS.PRA ABT BAC WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN MS WFC.PRY WFC.PRX WFC.PRW WFC.PRV ABT WFC WFC.WS BAC LOGM MS.PRI MS.PRK

10
Dexcom And The Missing Connection Between Stock Price And Fundamental Business

2018-07-09 seekingalpha
A hype will only happen with a new technology or invention, the possibility of a gigantic market and good news that lead to higher expectations.
ABT DXCM ABT

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to LSE:ABT / ABBOTT LABORATORIES on message board site Silicon Investor.

Westinghouse Air Brake Technologies Corporation (Wabtec Corp ABTG: Ambient Corp (Bulls Board)
Ambient Corporation - ABTG.OB ABT: Abbott Laboratories
ABT - Abbott Labs Autobytel (ABTL) - Buy Autos online
ABTXQ: AgriBioTech, Inc. ABTX: AgriBioTech, Inc.
Able Telecom (ABTE) ABTX - Agribiotech